Skip to content

Irinotecan Hydrochloride

Irinotecan Hydrochloride

Product Description
CAT No.
ALN-I010034
CAS No.
100286-90-6
Mol. F.
C33H38N4O6 : HCl
Mol. Wt.
586.7 : 36.5
Stock
Please Inquire
Chemical Name : (S)-4,11-Diethyl-4-hydroxy-3,14-dioxo-3,4,12,14-tetrahydro-1H-pyrano[3′,4′:6,7]indolizino[1,2-b]quinolin-9-yl [1,4′-bipiperidine]-1′-carboxylate hydrochloride
Smiles : O=C(OC(C=C1)=CC2=C1N=C(C(N3C4)=CC([C@@](O)(CC)C(OC5)=O)=C5C3=O)C4=C2CC)N(CC6)CCC6N7CCCCC7.Cl
Inchi : InChI=1S/C33H38N4O6/c1-3-22-23-16-21(43-32(40)36-14-10-20(11-15-36)35-12-6-5-7-13-35)8-9-27(23)34-29-24(22)18-37-28(29)17-26-25(30(37)38)19-42-31(39)33(26,41)4-2/h8-9,16-17,20,41H,3-7,10-15,18-19H2,1-2H3/t33-/m0/s1/i5D2,6D2,7D2,12D2,13D2

RP-HPLC method development and validation for the simultaneous estimation of Irinotecan hydrochloride and Capecitabine in Active Pharmaceutical Ingredients (APIs)

By Vijaya Jyothi, M.; Bhargav, E.; Keerthana, B.; Varalakshmi, Devi K.nFrom International Journal of Research in Pharmaceutical Sciences (Madurai, India) (2018), 9(1), 63-67

Method development, validation and forced degradation studies of Irinotecan in bulk and pharmaceutical dosage form

By Swathi, Koduru; Farooqui, Tahmeena; Muntaha, Sidra Tul; Ayesha, Syeda Amtul; Shama, Syeda; Siddiqui, Sarah Imam – From World Journal of Pharmacy and Pharmaceutical Sciences (2018), 7(8), 996-1009

Request For Quotation